Isokinetic Profile of Ankle Joint Muscles in Chronic Non Specific Low Back Pain Patients

NCT07636967 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2026-07-17

No results posted yet for this study

Summary

Chronic non-specific low back pain and its resulting infirmity have become a huge health and socioeconomic burden. Low back pain is reportedly associated with decreased activities of daily living and quality of life. Previous literature supports the presence of a link between CLBP and lower limb kinematics that can contribute to functional limitations and disability. For example, CLBP commonly coexist with postural and structural asymmetry. Ankle muscle performance of individuals with LBP during gait becomes more clinically important as it may provide insights into the mechanisms of ankle strategies. The isokinetic testing is an assessment method of high effectivity and trustworthiness that can be used to compare bilateral and agonist/ antagonist ankle muscles strength of normal subjects and athletes. It can be used to analyze muscular performance and differences in muscle performance between dominant and non-dominant limbs.

Conditions

  • Chronic Non-specific Low Back Pain

Interventions

DEVICE

Humac Isokinetic 2015 System 2

Humac isokinetic device will be used for testing and assessing ankle joint profile including torque, endurance, joint position, and time parameters for both limbs for 50 patients diagnosed with chronic non specific low back pain

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Maha Mostafa Alibeiny, Associate Professor · Cairo University

  • Hany Mohamed Hamed, Associate Professor · Faculty of Medicine, Kafrelsheikh University

Eligibility

Min Age
20 Years
Max Age
25 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-13
Primary Completion
2026-10-30
Completion
2026-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07636967 on ClinicalTrials.gov